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The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. Distinct
versions of the N-end rule operate in bacteria, fungi, and mammals. We report the cloning and analysis of aat,
the Escherichia coli gene that encodes leucyl, phenylalanyl-tRNA-protein transferase (L/F-transferase), a
component of the bacterial N-end rule pathway. L/F-transferase is required for the degradation of N-end rule
substrates bearing an N-terminal arginine or lysine. The aat gene maps to the 19-min region of the E. coli
chromosome and encodes a 234-residue protein whose sequence lacks significant similarities to sequences in
data bases. In vitro, LdF-transferase catalyzes the posttranslational conjugation of leucine or phenylalanine to
the N termini of proteins that bear an N-terminal arginine or lysine. However, the isolation and sequence
analysis of a 13-galactosidase variant engineered to expose an N-terminal arginine in vivo revealed the
conjugation of leucine but not of phenylalanine to the N terminus of the 13-galactosidase variant. Thus, the
specificity of L/F-transferase in vivo may be greater than that in vitro. The aat gene is located -1 kb from cipA,
which encodes a subunit of ATP-dependent protease Clp. Although both aat and cipA are required for the
degradation of certain N-end rule substrates, their neariy adjacent genes are convergently transcribed. The aat
gene lies downstream of an open reading frame that encodes a homolog of the mammalian multidrug resistance
P glycoproteins.
Among the functions of intracellular proteolysis are the
elimination of abnormal proteins, the maintenance of amino
acid pools in cells during stresses such as starvation, and the
generation of protein fragments that act as hormones, anti-
gens, or other effectors. Yet another role of proteolytic
pathways is to confer short half-lives on proteins whose
concentrations must vary with time or alterations in the state
of a cell. Thus, either a constitutive or a transient metabolic
instability is a property of many regulatory proteins. Many
other proteins, while long-lived as components of larger
complexes, such as ribosomes and oligomeric proteins, are
metabolically unstable as free subunits (for recent reviews,
see references 15, 20, 22, 28, 34, 36, and 45).
Amino acid sequences, conformational determinants, or
chemically modified protein structures that confer metabolic
instability are called degradation signals, or degrons (44). An
essential component of one degradation signal is the N-ter-
minal residue of the protein (2). The presence of this signal,
called the N-degron, is manifested as the N-end rule, which
relates the in vivo half-life of a protein to the identity of its
N-terminal residue. Distinct versions of the N-end rule have
been shown to operate in all organisms examined, from
mammals to bacteria (reviewed in reference 45).
In eukaryotes, linear ubiquitin (Ub) fusions to a test
protein, such as P-galactosidase (Pgal), are rapidly and
precisely deubiquitinated by endogenous Ub-specific pro-
cessing proteases (2). Deubiquitination occurs irrespective
of the identity of a residue at the Ub-IBgal junction and
results in free Ub and a Pgal variant bearing the previouslyjunctional residue at its new N terminus. This in vivo method
* Corresponding author.
for generating different residues at the N termini of other-
wise identical test proteins led to the discovery of the N-end
rule in eukaryotes (2). Subsequent isolation of UBP1, the
gene encoding one of the Ub-specific processing proteases of
the yeast Saccharomyces cerevisiae (43), and expression of
this enzyme in Escherichia coli made possible the use of Ub
fusions to test for the presence of an N-end rule in bacteria,
which lack Ub and Ub-specific enzymes.
Tobias and colleagues detected and defined the N-end rule
in E. coli and also showed that the gene aat is required for
the degradation of N-end rule substrates that bear N-termi-
nal Arg or Lys, whereas all classes of N-end rule substrates
(i.e., those bearing N-terminal Phe, Leu, Trp, Tyr, Arg, or
Lys) are stabilized by disruptions of the gene clpA (42). The
previously cloned clpA encodes a subunit of ATP-dependent
protease Clp (also known as protease Ti; for reviews, see
references 18 and 20). The aat locus was originally defined
by use of a mutant that lacked the activity of leucyl,
phenylalanyl-tRNA-protein transferase (L/F-transferase), an
enzyme that conjugates Leu or Phe to Arg or Lys at the N
termini of test substrates (40). The function of this enzyme,
which is present in bacteria but not in eukaryotes, was
revealed by the finding that N-end rule substrates bearing
N-terminal Arg or Lys are short-lived in E. coli in the
presence but not in the absence of L/F-transferase (42).
The N-end rule is thus organized hierarchically, with
N-terminal Arg and Lys being secondary destabilizing resi-
dues, in that they function as substrates for the conjugation
of either Leu or Phe, two of the four primary destabilizing
residues (Leu, Phe, Trp, and Tyr) in the E. coli N-end rule.
The N-end rule is also hierarchical in eukaryotes, but the
details are quite different (19). For example, in the yeast S.
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cerevisiae, N-terminal Arg and Lys are primary destabilizing
residues, while N-terminal Asp and Glu are secondary
destabilizing residues, in that they function as substrates for
the conjugation of Arg, one of the primary destabilizing
residues in eukaryotes. The conjugating enzyme, arginyl-
tRNA-protein transferase (R-transferase), is not found in
bacteria (14).
The present work extends our initial findings about the E.
coli N-end rule (42). First, we describe the cloning and
analysis of the aat gene. Second, an N-end rule substrate,
such as Arg-pgal (a 3-gal variant engineered to expose an
N-terminal arginine), is modified in vivo through the N-ter-
minal conjugation of Leu but not of Phe. Third, aat is only
-1 kb away from the previously characterized, convergently
transcribed cipA gene, which encodes a subunit of protease
Clp, another component of the N-end rule pathway. Finally,
the aat gene is part of a new operon that also encodes a
homolog of the mammalian multidrug resistance (Mdr) P
glycoproteins.
MATERIALS AND METHODS
Bacterial strains and media. E. coli MC1061 [hsdR mcrB
araD139 A(araABC-leu)7679 AlacX74 galU galK rpsL thi]
was used as the parental strain throughout this work. Vari-
ants of this strain were constructed by P1 transduction (38).
In particular, strain TS360 (MC1061 recD1903::minitet),
which allows targeted homologous recombination to be
carried out by transformation with linear DNA fragments,
was constructed from MC1061 by use of a Plvir lysate grown
on strain DPB271 (recD1903::minitet) (6). TS365 (MC1061
pcnB80 zad::minikan), in which ColEl-like plasmids, such
as pBR322, have a decreased copy number, was constructed
by use of a Plvir lysate grown on strain MJC112 (pcnB80
zad::minikan) (32; a gift from M. Carson, Harvard Medical
School, Boston, Mass.). The liquid medium was Luria broth
(1% Bacto Tryptone, 0.5% yeast extract [Difcol, 1% NaCl).
The solid medium contained 2% Bacto Agar (Difco). Anti-
biotics (Sigma) were added as needed to the following final
concentrations: 100 ,g of ampicillin, 10 ,g of tetracycline,
34 ,ug of chloramphenicol, and 25 ,ug of kanamycin per ml.
5-Bromo-4-chloro-3-indolyl-13-D-galactopyranoside (X-Gal;
Boehringer), a chromogenic Pgal substrate, was added as
needed to 0.006%.
Plasmids. Plasmid pAS1 is a derivative of pBR322 (8) that
was constructed by replacing the -2-kb EcoRI-PvuII frag-
ment of pBR322 with a -0.12-kb EcoRI-PvuII fragment of
pGEM2-Ava that contains a polylinker cloning region (37).
Each of the pUBP-X-fgal plasmids expressed both the
Ub-specific processing protease Ubpl of S. cerevisiae and 1
of the 20 Ub-X-Pgal fusion proteins (where X is any amino
acid) (see above). This set of plasmids was constructed by
isolating the -5.3-kb ScaI fragments of pUB23-X plasmids
(2), which encode the Ub-X-Pgal fusion proteins, ligating
BglII linkers to the ends of the fragments, and inserting each
of the fragments into the BamHI site of plasmid pJT184,
which encodes Ubpl (43). The resulting pUBP-X-,Bgal plas-
mids expressed Ub-X-fgal and Ubpl from yeast promoters
that are weakly active in E. coli (42). These plasmids
contained the plSA replicon and a cat gene from plasmid
pACYC184 that conferred, respectively, compatibility with
ColEl replicon-based plasmids and resistance to chloram-
phenicol (11). The construction of other plasmids is de-
scribed below.
Transposon mutagenesis. Minitet transposon insertions
into the E. coli chromosome that inhibited the degradation of
normally short-lived Arg-IBgal were generated by the "X-
hop" method (46). In brief, MC1061 cells carrying the
pUBP-R-iBgal plasmid were infected with XNK1098 (46),
plated on medium containing tetracycline, and screened for
tetracycline-resistant (Tetr) colonies. MC1061 is supo and
therefore does not support the replication or integration of
XNK1098, which carries a Pam8O amber mutation in its P
gene and the b522 deletion, which removes the phage
attachment site. Thus, a Tetr colony would be derived from
a cell in which the minitet transposon of XNK1098 has
"hopped" from the phage into the E. coli chromosome.
Minitet transposon insertions that inhibit Arg-13gal degrada-
tion result in elevated intracellular levels of Arg-jBgal; such
cells form blue colonies in the presence of X-Gal (see Results
and reference 42). Approximately 15,000 Tetr colonies were
screened for high Arg-IBgal levels on X-Gal plates. Putative
Arg-13gal degradation mutants were tested further by curing
the cells of pUBP-R-Pgal through growth in the absence of
chloramphenicol and retransforming cured cells with inde-
pendently isolated pUBP-X-Pgal plasmids.
Identification of minitet insertion sites. The insertion sites
were determined by direct sequencing of minitet-E. coli
DNA junctions. Total DNA from mutants TS351 and TS357,
which were defective in the degradation of Arg-pgal (see
Results), was prepared (38) and digested with BamHI. Since
BamHI does not cut within the minitet sequence, complete
digestion yields a minitet-containing DNA fragment flanked
on both sides with E. coli DNA. Minitet-containing frag-
ments were isolated by ligating the BamHI-produced E. coli
DNA fragments into BamHI-digested pAS1, transforming
the resulting library into TS365, and selecting for Tetr
transformants. TS365 contains a mutation in the pcnB gene
that lowers the copy number of ColEl-like plasmids such as
pBR322 and pAS1 (32) and therefore allows the use of the
TnlO-derived tet gene, which is lethal when expressed from
a multicopy plasmid in wild-type cells (29). For preparation
of larger quantities of minitet-E. coli DNA junctions for
sequencing, minitet-containing BamHI fragments were di-
gested with EcoRI, which cuts within the tet gene, yielding
fragments that were no longer lethal at a high copy number.
These fragments were ligated into BamHI-EcoRI-cut pAS1
and transformed into MC1061. Plasmid DNA was isolated
from transformants by the alkaline lysis procedure (1).
Nucleotide sequencing was carried out by the chain termi-
nation method with standard procedures (1) and primers
complementary to the ends of the minitet element (47). The
sequences of the actual minitet insertion sites, 5'-CACA
CAGCA-3' (TS351 mutant) and 5'-CGCAAAGCA-3' (TS357
mutant), were similar to the consensus sequence for TnJO
insertions, 5'-NGCIJNAGCN-3' (29). These sequences are
identical to positions 2363 to 2371 of Fig. 1, which lie within
the aat gene (see below), and to positions 2773 to 2781 of the
previously published sequence of the clpA gene (21); the
latter positions correspond to positions 4592 to 4584 in the
numbering scheme of Fig. 1.
Mapping, cloning, and sequencing of the aat gene. Hfr and
P1 mapping of the class I and II minitet insertions (see
Results), which inhibited the degradation of Arg-,Bgal, was
performed as described previously (38) with mutants that
carried pUBP-R-13gal. Inclusion of this plasmid allowed for
easy monitoring of the ability of a particular Hfr donor strain
or Plvir lysate to correct the mutant cell's defect in Arg-,Bgal
degradation. The restoration of Arg-pgal degradation by Hfr
mating or P1 transduction resulted in the appearance of
white colonies on X-Gal plates. Polymerase chain reaction
mapping was carried out with a GeneAmp kit (Perkin-Elmer
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CCCATCGTCAGGAGGAGOATTTAAATGCGCGCTTTGCTACCCTATCTGGCACTGTATAAACGTCATAAATGGATGTTAAGTCTTGGTATTGTGCTGGCAATTGTGA 105
M R A L L P Y L A L Y K R H K W M L S L G I V L A I V T 28
CGCTGCTCGCCAGTATCGGTCTGTTGACACTTTCCGGCTGGTTCCTCTCGGCCTCAGCGGTTGCGGGGGTTGCCGGACTGTACAGCTTCAACTATATGCTACCCG 210
L L A S I G L L T L S G W F L S A S A V A G V A G L Y S F N Y M L P A 63
CTGCGGGCGTGCGTGGCGCAGCAATCACCCGTACTGCCGGGCGCTATTTTGAACGTCTGGTAAGTCACGACGCGACTTTCCGCGTGTTGCAGCATCTGCGCATTTl~l' 315
A G V R G A A I T- R T A G R Y F E R L V S H D A T F R V L Q H L R I Y 98
ACACCTTCAGCAAATTGCTGCCCCTCTCCCCTGCCGGACTGGCGCGCTATCGTCAGGGCGAATTGCTCAATCGCGTGGTGGCGGATGTTGATACGCTCGATCATC 420
T F S K L L P L S P A G L A R Y R Q G E L L N R V V A D V D T L D H L 133
TTTACCTGCGCGTTATCTCGCCGCTGGTGGGCGCTTTTGTGGTGATTATGGTGGTGACAATCGGGTTAAGTTTCCTTGATTTCACCCTCGCCTTTACGCTGGGCG 525
Y L R V I S P L V G A F V V I M V V T I G L S F L D F T L A F T L G G 168
GCATTATGTTACTGACGCTTTTCCTGATGCCACCGCTGTTTTATCGTGCGGGAAAAAGCACCGGGCAAAATCTGACTCATCTTCGCGGACAGTATCGCCAACAAC 630
I M L L T L F L M P P L F Y R A G K S T G Q N L T H L R G Q Y R Q Q L 203
TGACGGCCTGGCTGCAAGGGCAAGCTGAGCTGACCATTTTTGGTGCCAGCGATCGTTATCGCACGCAACTAGAGAATACAGAAATTCAATGGCTGGAAGCGCAAC 735
T A W L Q G Q A E L T I F G A S D R Y R T Q L E N T E I Q W L E A Q R 238
GCCGTCAATCTGAACTGACCGCATTGTCGCAAGCGATAATGCTGCTCATTGGCGCGTTAGCGGTGATCCTGATGCTGTGGATGGCGTCTGGCGGCGTTGGCGGCA 840
R Q S E L T A L S Q A I M L L I G A L A V I L M L W M A S G G V G G N 273
ATGCTCAACCCGGCGCGTTAATTGCCCTGTTTGTCTTCTGCGCGTTAGCCGCGTTTGAAGCACTGGCACCAGTAACGGGTGCATTTCAGCATCTGGGGCAAGTCA 945
A Q P G A L I A L F V F C A L A A F E A L A P V T G A F Q H L G Q V I 308
TTGCCTCTGCCGTACGTATCTCTGACTTAACGGATCAAAAACCGGAGGTCACCTTTCCTGATACCCAAACTCGTGTTGCCGATCGCGTTTCGCTGACGTTACGGG 1050
A S A V R I S D L T D Q K P E V T F P D T Q T R V A D R V S L T L R D 343
ATGTTCAGTTCACTTATCCGGAGCAATCTCAACAGGCACTTAAAGGGATTTCTCTTCAGGTAAACGCCGGGGAACATATAGCGATTCTCGGGCGAACCGGATGCG 1155
V Q F T Y P E Q S Q Q A L K G I S L Q V N A G E H I A I L G R T G C G 378
GCAAATCAACACTGTTACAACAGCTGACCCGCGCATGGGACCCGCAACAGGGCGAGATTTTGCTTAACGATAGCCCCATAGCCAGCCTGAATGAAGCGGCTCTAC 1260
K S T L L Q Q L T R A W D P Q Q G E I L L N D S P I A S L N E A A L R 413
GACAGACCATCAGCGTTGTTCCTCAGCGAGTGCATCTGTTTAGCGCCACGCTGCGTGATAATCTTTTACTCGCCTCGCCTGGCAGTAGTGATGAGGCTCTGTCGG 1365
Q T I S V V P Q R V H L F S A T L R D N L L L A S P G S S D E A L S E 448
AGATCTTGCGTCGCGTTGGCCTGGAAAAGCTGCTCGAGGATGCAGGTCTCAACAGTTGGTTAGGTGAAGGCGGACGCCAGCTCTCCGGTGGTGAACTGCGCCGTC 1470
I L R R V G L E K L L E D A G L N S W L G E G G R Q L S G G E L R R L 483
TGGCTATCGCCCGTGCGCTGTTACATGATGCGCCACTGGTGTTGCTGGATGAACCTACCGAAGGCTTAGATGCCACAACCGAAAGCCAGATCCTTGAATTGCTTG 1575
A I A R A L L H D A P L V L L D E P T E G L D A T T E S Q I L E L L A 518
CAGAAATGATGCGTGAGAAAACGGTGTTAATGGTCACCCATCGACTTCGCGGACTCTCTCGTTTCCAACAAATAATAGTGATGGACAACGGGCAAATTATTGAGC 1680
E M M R E K T V L M V T H R L R G L S R F Q Q I I V M D N G Q I I E Q 553
AAGGTACTCACGCAGAACTGCTTGCCAGACAGGGGCGTTATTACCAGTTCAAGCAGGGTTTGTAAGCTATTATTGAACGATCCGACTTGCGTGGAGTTTTG GGT 1785
G T H A E L L A R Q G R Y Y Q F K Q G L (573)
CATGCGCCTGGTTCAGCTTTCTCGCCATTCAATAGCCTTCCCTTCCCCGGAAGGCGCATTACGTGAGCCTAACGGCCTGCTGGCACTTGGGGGCGATCTTAGCCC 1890
M R L V Q L S R H S I A F P S P E G A L R E P N G L L A L G G D L S P 35
TGCGCGCCTGTTAATGGCTTACCAGCGTGGTATTTTTCCGTGGTTTTCTCCAGGCGACCCCATCCTCTGGTGGTCGCCCGATCCCCGCGCGGTGCTATGGCCAGA 1995
A R L L M A Y Q R G I F P W F S P G D P I L W W S P D P R A V L W P E 70
ATCACTGCATATCAGCCGTAGTATGAAGCGATTTCATAAACGCTCGCCCTATCGTGTCACGATGAATTACGCTTTTGGTCAGGTCATTG3AAGGCTG3TGCCAGCGA 2100
S L H I S R S M K R F H K R S P Y R V T M N Y A F G Q V I E G C A S D 105
TCGCGAAGAAGGAACCTGGATCACGCGTGGCGTGGTCGAAGCCTACCATCGCCTTCACGAACTCGGCCATGCCCACTCCATTGAAGTCTGGCGTGAAGATGAGCT 2205
R E E G T W I T R G V V E A Y H R L H E L G H A H S I E V W R E D E L 140
TGTCGGCGGTATGTACGGCGTGGCCCAGGGAACGCTATTTTGTGGCGAGTCCATGTTCAGCCGGATGGAAAATGCGTCTAAAACGGCGCTTCTGGTATTCTGTGA 2310
V G G M Y G V A Q G T L F C G E S M F S R M E N A S K T A L L V F C E 175
GGAATTTATCGGTCATGGCGGTAAGCTTATCGACTGCCAGGTCCTTAACGATCACACAGCATCGCTTGGTGCCTGCGAAATTCCCCGCCGGGATTACCTTAATTA 2415
E F I G H G G K L I D C Q V L N D H T A S L G A C E I P R R D Y L N Y 210
TCTCAATCAAATGCGCCTCGGACGATTGCCGAATAATTITCTGGGTACCACGATGCTTGTTTTCACCACAAGAATGAATGTTTTCGGCACATTTCTCCCCAGAGTG 2520
L N Q M R L G R L P N N F W V P R C L F S P Q E (234)
TTATAATTGCGGTCGCAGAGTTGGTTACGCTCATTACCCCGCTGCCGATAAGGAATTTTTCGCGTCAGGTAACGCCCATCGTTTATCTCACCGCTCCCTTATACG 2625
TTGCGCTTTTGGTGCGGCTTAGCCGTGTGTTTTCGGAGTAATGTGCCGAACCTGTTTGTTGCGATTTAGCGCGCAAATCTTTACTTATTTACAGAACTTCGGCAT 2730
TATCTTGCCGGTTCAAATTACGGTAGTGATACCCCAGAGGATTAGATGGCCAAAGAAGACAATATTGAAATGCAAGGTACCGTTCTTGAAACGTTGCCTAATACC 2835
M A K E D N I E M Q G T V L E T L P N T 20
ATGTTCCGCGTAGAGTTAGAAAACGGTCACGTGGTTACTGCACACATCTCCGGTAAAATGCGCAAAAACTACATCCGCATCCTGACGGGCGACAAAGTGACTGTT 2940
M F R V E L E N G H V V T A H I S G K M R K N Y I R I L T G D K V T V 55
GAACTGACCCCGTACGACCTGAGCAAAGGCCGCATTGTCTTCCGTAGTCGCTGATTGTTTTACCGCCTGATGGGCGAAGAGAAAGAACGAGTAAAAGGTCGGTTT 3045
E L T P Y D L S K G R I V F R S R (72)
AACCGGCCTTTTTATTTTGTGATATGTATGAAGTACTTTGGAAGTATAAGTCCGTAACTTGTCTCGATGTAGATATACTGCACAACTTGTTTACAGTATGAGCAA 3150
ACAATAATTATCATTAAAATTCTTCTTGACCGTTTTACTCCAACTCCCTATAGTAGCGCCCCGTTGCCACCCATGAGGTTTGGTAGCAAAACAATTTGGTGAGGT 32SS
5,->
GTCCGAGTGGCTGAAGGAGCACGCCTGGAAAGTGTGTATACGGCAACGTATCGGGGGTTCGAATCCCCCCCTCACCGCCATATTTAAAGAAGAGCTCGTACGAAA 3360
->3,
GI'GCGAGCTTTTTTTTCGCATTTTATCTGTCTGTACGGCAGTGAACATGGTGGGCGGGTGGAGTATGTTACCTGTGAATTTCTAAGCTGCCTGTACGGCAGTGAA 3465
CTCAAATACTACACGTTTAGCCCGTTGTTAATAAAGCAAAACCATCCCATTCTCCTGCAGCACCCTTTTTTATCCTTACCTTCCCGCAGCACTAATTATCAACAA 3570
CTTACCATCATCATTAAAAAAAGGGTCTGAACCTCCTCCACCCCATAAACAAAAAGTCCGTAACCTCTTTCGAGATTACGGACTTGACCAACCTACCTAACAATC 367S
AGATTAA 3682
FIG. 1. Nucleotide sequence of a -3.5-kb region of the E. coli chromosome at the 19-min (-930-kb) map position and deduced amino acid
sequences of the corresponding proteins. The nucleotide sequence is presented in the direction opposite that in the standard genetic map to
indicate the deduced translation products. The sequence shown contains the mdrH (24 to 1745), aat (1787 to 2491), infA (2776 to 2994), and
serW (3213 to 3335) genes. Nucleotides 3679 to 3681 of this sequence correspond to the stop codon of the convergently transcribed cipA gene
(21). The putative Shine-Dalgarno sequences for mdrH, aat, and infA are underlined. Nucleotide sequence data for a portion of this region
have been published elsewhere (12, 21). Our data differ from those published in reference 12 at positions 3585 (no nucleotide in reference 12),
1583 (C in reference 12), and 1620 (no nucleotide in reference 12). These differences result in an alteration of the deduced amino acid sequence
of the MdrH protein encoded by this region. In addition, our sequence data differ from those reported in reference 21 at positions 3585 (no
nucleotide in reference 21) and 3602 (no nucleotide in reference 21).
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FIG. 2. Diagram of the aat region of the E. coli chromosome. Also shown are the genomic DNA fragments that complemented the
Arg-Ogal degradation defect in TS351 cells and a noncomplementing clone that contains an internal deletion. Abbreviations: H, HindIII; G,
BglII; R, EcoRI; P, PstI; C, ScaI; K, KpnI; S, SspI; A, AvaI; (+), complementation of the Arg-Pgal degradation defect; (-), lack of
complementation; (+/g), complementation with a small-colony phenotype.
Cetus) and genomic DNA isolated from strains TS351 and
TS353, which contained distinct minitet insertions in the aat
gene. One polymerase chain reaction primer (5'-GCCG
GATCCGTAATCTCGAAAGAGG-3') was complementary
to the 3' end of the cipA gene (21); the other primers were
complementary to unique sequences near the ends of the
minitet sequence (5'-GCCGGATCCATTGCTGTTGAC-3'
and 5'-GCCGGACCCTfIGGTGACCAACGC-3') (47). A
-6-kb EcoRI genomic DNA fragment containing the 3' end
of the cipA gene and downstream sequences was isolated
from phage 213 (iH1) of the Kohara library (30) and cloned
by use of the pASl cloning vector. This EcoRI fragment is
toxic in wild-type cells, so the initial cloning and subcloning
steps were carried out with strain TS365, in which the copy
number of these ColEl-based plasmids is reduced to non-
toxic levels (32). After construction in strain TS365, sub-
clones were tested for toxic effects by transformation into
MC1061 cells. The region of the EcoRI fragment shown in
Fig. 1 was sequenced on both strands by the chain termina-
tion method (1).
Subcloning and deletion analysis of the aat gene. A series of
deletions near the 5' end of the aat open reading frame
(ORF) were produced by published procedures (1) with
minor modifications. In brief, the 1,711-bp BglII-ScaI frag-
ment that contained the entire aat gene (Fig. 2) was ligated to
BamHI-SmaI-digested pGEM2 (Promega), yielding pAS17.
This plasmid (10 ,g) was linearized with AvaI and PstI to
yield a fragment with one 5' overhang and one 3' overhang
(see Fig. 4A). This fragment was treated with exonuclease
III (New England Biolabs) for 20, 30, 60, 105, 135, and 180 s
to produce a nested set of deletions of the 5' strand that
encompassed the 5' end of the aat ORF. The resulting 3'
overhangs and the 3' overhang generated by PstI were
removed by treating the samples sequentially with S1 nucle-
ase and Klenow polymerase I (Boehringer). The DNA was
purified to remove nuclease buffers by use of GeneClean
(Bio 101, Inc.), resuspended in TE buffer (1 mM EDTA, 10
mM Tris-HCl [pH 8.0]), and circularized by use of T4 DNA
ligase (Bethesda Research Laboratories). Ligation mixtures
from different exonuclease III time points were cotrans-
formed into E. coli TS351 (MC1061 aat-2::minitet) together
with pUBP-R-Pgal. Transformation mixtures were plated on
a solid medium containing chloramphenicol, ampicillin, tet-
racycline, and X-Gal. The transformation mixture from the
30-s exonuclease III digestion had a particularly convenient
mixture of white and blue colonies. Plasmid DNA was
prepared by alkaline lysis (1) from 13 transformants derived
from the 30-s time point, and the 5' region of aat in these
isolates was sequenced by use of a primer complementary to
the T7 polymerase promoter in the polylinker of pGEM2.
A second deletion series was produced by use of a plasmid
in which a strong transcriptional terminator (T14) was posi-
tioned immediately upstream of the aat gene, thereby reduc-
ing the probability that a cryptic transcript originating in the
vector DNA would complicate attempts to determine the
minimum upstream regions required for the expression of
LUF-transferase. Plasmid pAS44 was constructed by insert-
ing a 2,967-bp ScaI-EcoRI fragment from plasmid pRS415
(39) into ScaI-EcoRI-cut pGEM2. This fragment contained
four tandem copies of the strong transcriptional terminator
from the E. coli rRNA operon (9). The pAS45 vector used in
the second deletion series was constructed by inserting the
BglII-SspI fragment that contained the aat gene (Fig. 2) into
BamHI-PvuII-cut pAS44. For the deletion series, pAS45
was digested with SacI and AvaI, creating a linear fragment
with a 3' overhang immediately downstream of the T14
terminator and a 5' overhang 389 bp upstream of the aat start
codon. Deletions from the 5' overhang were made, and the
resulting fragments were recircularized as described above.
Ligation products were transformed into TS351 containing
pUBP-R-Pgal as described above.
Plasmids pAS31 and pAS32 were constructed by inserting
the PvuII (a site within pGEM2)-SspI (position 2,791 in Fig.
1) fragment from deletion clones W1 and W3 (see Fig. 4A)
into the EcoRV site of pBR322. Plasmid pAS25 was con-
structed from pAS17 by deleting the 346-bp KpnI fragment
that spans the region from the 3' end of the aat gene to the
5' end of the infA gene (see Fig. 4A).
N-terminal sequence analysis of an N-end rule substrate.
Isolates of E. coli JT111 (lacIq clpA14::minitet) were
cotransformed with a pKKUb-X-Pgal plasmid (where X is
any amino acid) that expressed a Ub-X-Pgal fusion from the
powerful Ptrc promoter and with plasmid pJT184, which
encoded the Ub-specific protease Ubpl of S. cerevisiae.
X-,Bgal proteins (where X is any amino acid) were purified by
APTG-Sepharose chromatography as described previously
(19). The purified X-Pgal proteins were fractionated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to ProBlot membranes (Applied Biosystems)
in accordance with the manufacturer's recommendations.
N-terminal sequencing of X-Pgal proteins (five cycles of
Edman degradation) was performed by use of an Applied
Biosystems model 477 protein sequencer at the Massachu-
setts Institute of Technology Biopolymers Laboratory.
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Nucleotide sequence accession number. The nucleotide
sequence reported in this paper has been submitted to the
GenBank-EMBL data bank and assigned accession number
L10383.
RESULTS
Screen for mutations in the N-end rule pathway. We used
transposon mutagenesis to identify genes whose inactivation
perturbs the N-end rule pathway in E. coli. Mutagenesis was
performed with a strain that expressed both the Ub-Arg-pgal
fusion protein and Ubpl, one of the Ub-specific processing
proteases of S. cerevisiae (3, 43) (see Materials and Meth-
ods). When expressed in E. coli, the yeast Ubpl protease
efficiently and precisely deubiquitinates Ub-Arg-pgal and the
other Ub-X-Pgal fusions, Ub-Pro-pgal being the single ex-
ception (43). These Ub fusions were not deubiquitinated in
E. coli lacking yeast Ubpl, and the unprocessed fusions
were invariably long-lived. In contrast, the X-IBgal proteins
produced from Ub-X-Pgal fusions in Ubpl-expressing E. coli
were either long-lived or unstable, depending on the identity
of their N-terminal residues. These measurements, carried
out with 19 Ub-X-IBgal fusions, yielded the N-end rule in E.
coli (42).
Arg-Pgal bears one of the two secondary destabilizing
N-terminal residues in the E. coli N-end rule (secondary
destabilizing residues require N-terminal conjugation of a
primary destabilizing residue prior to substrate degradation).
Therefore, Arg-Pgal could serve as a reporter for detecting
changes in the activity of the N-end rule pathway toward
substrates bearing either secondary or primary destabilizing
N-terminal residues. Transposon insertions into the E. coli
chromosome that inhibited the degradation of Arg-IBgal were
generated by TnlO mutagenesis by the X-hop method (46). In
this procedure, cells are infected with a nonreplicating,
nonintegrating X phage carrying the TnlO transposase and a
short (-2-kb), TnlO-derived transposable element (minitet)
containing the tetracycline resistance gene of TnlO (46). A
hop of minitet results in a tetracycline-resistant (Tetr) col-
ony. Among such Tetr cells may be minitet insertion mutants
unable to degrade Arg-IBgal. Such mutants are identifiable as
those that form blue colonies on plates containing X-Gal, a
chromogenic indicator of P3gal activity. Cells that degrade
Arg-Pgal efficiently do not accumulate significant steady-
state levels of Pgal and therefore form white colonies on
X-Gal plates (5, 42).
Approximately 1 in 1,500 minitet insertions rendered E.
coli MC1061 unable to degrade Arg-Pgal. Examination of the
ability of the mutant to degrade Leu-pgal, which bears one of
the primary destabilizing N-terminal residues (requiring no
modification prior to substrate degradation) divided these
minitet insertions into two classes. Class I mutations failed
to degrade both types of N-end rule substrates, represented
by Arg-IBgal and Leu-,3gal, while class II mutants were
unable to degrade Arg-Pgal but were unimpaired in the
degradation of Leu-Pgal.
Insertions that stabilize both Arg-fgal and Leu-pgal residein the cipA gene. Genomic DNA fragments containing a
minitet insertion from class I mutant TS357 were isolated
and sequenced as described above. A comparison of the E.
coli DNA adjacent to minitet in mutant TS357 with se-
quences in data bases showed that the transposon resided
within previously analyzed cipA. The cipA gene encodes one
of the two subunits of ATP-dependent protease Clp (26, 27).
We conclude, in agreement with earlier findings (42), that the
Clp protease is essential for the degradation of N-end rule
substrates.
Insertions that stabilize Arg-,3gal but not Leu-jpgal reside in
the aat gene. A minitet insertion from mutant TS351 that
stabilized Arg-ogal but not Leu-fgal was found to reside
within a previously sequenced region of the E. coli chromo-
some; we also sequenced this region, as well as an adjoining,
previously unsequenced -1.5-kb stretch (see Materials and
Methods, Fig. 1, and reference 12). Our earlier work (42)
suggested that the insertion in TS351 inactivated a gene for
LIF-transferase, a biochemically characterized enzyme that
conjugates Leu or Phe to N termini of proteins or peptides
bearing N-terminal Arg or Lys (40). Indeed, an E. coli
mutant (MS845 aat-1) that lacked L/F-transferase activity
(41) was recently shown to have an N-end rule defect
indistinguishable from that in the minitet-generated class II
mutant in the present work (stabilization of Arg-Pgal but not
of Leu-fBgal) (42).
Mapping experiments with both Hfr mating and P1 trans-
duction demonstrated that the sites of our class II minitet
insertions, such as the one in TS351, were indeed extremely
close to the site of an aat mutation identified earlier (MS845
aat-1 produced by chemical mutagenesis) in a gene termed
aat by Soffer and Savage (41). These sites and the cipA gene
both mapped at -19 min in the E. coli genome (see Materials
and Methods). Southern hybridization to genomic DNA
from class I (TS354 and TS357) and class II (TS351 and
TS353) mutants with minitet as a probe indicated that all
insertions resided in the same -10-kb BamHI fragment (data
not shown). Furthermore, polymerase chain reaction map-
ping with genomic DNA isolated from the TS351 and TS353
(class II) mutants and oligonucleotide primers complemen-
tary to the 3' end of cipA and to the tet gene of minitet (see
Materials and Methods) demonstrated that the transposon
insertions of TS351 and TS353 were within -1.5 kb of the 3'
end of cipA (data not shown).
aat gene. DNA fragments encompassing cipA and the
downstream region of the E. coil genome were isolated from
phages 212 and 213 of the Kohara library (30), and an
-3.5-kb region downstream of cipA was sequenced. The
minitet insertion in mutant TS351 that resulted in the inhibi-
tion of Arg-,gal degradation resided within an ORF of a gene
(aat) that encoded a neutral (calculated pI, 7.2) 234-residue
protein (Fig. 1) whose molecular mass was close to the
reported molecular mass of the isolated L/F-transferase (40).
The position of the start (ATG) codon in aat was inferred so
as to yield the longest ORF. This start codon was preceded
by a moderately strong Shine-Dalgarno sequence, GGAG
(Fig. 1).
The deduced amino acid sequence of the Aat protein lacks
significant similarities to the sequence of Atel, the catalyti-
cally similar R-transferase of S. cerevisiae shown previously
to be a component of the N-end rule pathway in eukaryotes
(4). As expected for an enzyme that interacts with RNA, the
aat-encoded L/F-transferase contains arginine-rich regions;
however, it lacks known RNA-binding motifs, such as those
seen in transcriptional termination factors (31). In addition,
the sequence of Aat lacks "signature" sequences of ami-
noacyl-tRNA synthetases (10) and also is not similar to other
sequences in the current data bases. Thus, it is likely that
LF-transferase recognizes tRNA moieties of Leu-tRNAJPu
and Phe-tRNAPhe in a novel manner. As described below,
the -1-kb DNA fragment containing exclusively the aat
ORF complemented the Arg-ogal degradation defect in both
the TS351 mutant (minitet insertion) and the original aat
mutant (produced by chemical mutagenesis) (41). This re-
J. BACTERIOL.
N-END RULE IN E. COLI 4369
sult, together with indistinguishable map positions of the
original aat mutation and minitet insertions in our class II
mutants (see above), indicated that the aat gene of Soffer
and Savage (41) and the gene whose inactivation yielded
class II mutants in the present work are one and the same
gene.
aat operon. Although cipA and aat are located less than 1
kb apart and encode components of the same pathway, they
were found to reside in different operons. As shown in Fig.
2, cipA and aat are separated by previously characterized
gene infA, which encodes translational initiation factor Infl,
and by the serW gene, which encodes tRNAS"r. There are
putative transcriptional terminators between the 3' end of
infA and the 5' end of serW (12) and between the 3' end of
serW and the 3' end of the convergently transcribed cipA
gene (21). Thus, the two N-end rule genes, aat and cipA,
while nearly adjacent, are oriented in opposite directions and
are not coupled transcriptionally.
A 1.7-kb region immediately upstream of the aat gene was
sequenced and found to contain an ORF encoding a 573-
residue protein. The amino acid sequence of this protein is
similar to the sequences of Mdr P glycoproteins found in
mammalian cells and also to the sequences of other members
of the ATP-binding cassette family of membrane transport-
ers found in other species. A comparison between the
deduced amino acid sequences of this E. coli protein (tenta-
tively named MdrH, for Mdr homolog) and the CyaB protein
from Bordetellapertussis (17) is shown in Fig. 3. B. pertussis
is the etiologic agent of whooping cough; the cyaB gene
encodes an Mdr homolog required for export of the calmod-
ulin-sensitive adenylate cyclase-hemolysin protein. This bi-
functional secreted protein (encoded by the cyaA gene)
contributes to elevated levels of intracellular cyclic AMP
found in susceptible eukaryotic cells exposed to B. pertussis.
The deduced amino acid sequences of the E. coli MdrH and
B. pertussis CyaB proteins show significant similarities in
their C-terminal halves (Fig. 3). In addition, the N-terminal
half of each protein contains several stretches of hydropho-
bic residues that are likely to be membrane-spanning seg-
ments. The ATP-binding motif (23) resides in the C-terminal
half of each protein. The sequence of MdrH is more similar
to that of CyaB than it is to the sequences of bacterial
importers, such as histidine permease HisP or oligopeptide
permease OppF (24), suggesting that MdrH is involved in
peptide or protein export from E. coli. Transcriptional
coupling (see below) of the genes encoding L,/F-transferase
and the putative transporter MdrH is consistent with the
possibility that L/F-transferase may also have a function
outside the N-end rule pathway.
The mdrH and aat genes are separated by only 42 bp (Fig.
1). This intergenic region does not contain palindromic DNA
sequences capable of forming relatively stable hairpins char-
acteristic of transcriptional terminators. Furthermore, the
only run of T residues in this intergenic region, a second
common feature of transcriptional terminators (48), is
present between the Shine-Dalgarno sequence and the start
codon of the aat gene, an unlikely position for a transcrip-
tional terminator. Deletion analyses, described below, con-
firmed that this region allows readthrough transcription and
corroborated earlier data from S1 nuclease mapping experi-
ments carried out during studies of the transcriptional regu-
lation of the infA gene (12), which is located between aat and
cipA (Fig. 2). These studies demonstrated that the aat gene(referred to as ORF-27 in reference 12) was transcriptionally
coupled to an upstream region that contained the mdrH ORF
of the present work. In contrast, the infA gene was shown to
be expressed from two moderately strong promoters located
downstream of aat. As a result, the infA gene is transcribed
at a much higher level than its upstream neighbors (12). We
conclude that the aat gene is the last gene of a new operon
that contains at least one other gene.
Evidence for an intraoperon promoter upstream of the aat
gene. The transcriptional coupling of aat to mdrH suggests
that the physiologically relevant promoter for L/F-trans-
ferase expression resides far upstream of the aat gene.
However, ColEl plasmid-based clones containing either the
BglII (1366)-ScaI (3077) or the BglII (1366)-SspI (2791)
fragment and encoding the entire aat gene but only a fraction
of the upstream mdrH gene were found to complement the
Arg-Ogal degradation defect of TS351 cells. Furthermore,
the sequence immediately upstream of the aat ORF (Fig. 1)
resembles the consensus sequence of a a70-dependent E. coli
promoter (25), suggesting that aat could be expressed from
either a polycistronic mRNA (see above) or a monocistronic
message initiated immediately upstream of aat. We used
exonuclease III digestion to define the sequences that are
essential for the above-described complementation.
The extent of exonuclease III-mediated deletions and the
appearance of colonies of TS351(pUBP-R-Pgal) cells trans-
formed with the recircularized deletion products are shown
in Fig. 4. A reduced colony size was observed for cells
transformed with the majority of the clones produced in this
deletion series (Fig. 4A). The growth defect resulted from
the inclusion of a complete copy of the infA gene on a
multicopy plasmid (see below). Curiously, previous studies
done with a different genetic background revealed no growth
defect in cells that overexpressed the Infl protein (12). The
origin of this discrepancy remains to be determined.
The results from the initial deletion series were unex-
pected in that clones W2 and W3, which complemented fully
TS351 cells for Arg-Ogal degradation, and clones M7 to M12,
which complemented partially, were all shorter than the
complete aat ORF (Fig. 4A). A resolution of this paradox is
suggested by noting the reading frames of active or partially
active clones in Fig. 4A. Deletion clones W2, M7, M8, M9,
and Mll all started in the reading frame identical to the aat
OFR, while clones W3, M10, and M12 started in the -1
reading frame. Conversely, clone B13, which showed no
complementation, contained more upstream DNA than the
partially complementing clones but started in the + 1 reading
frame. We therefore suspected that the expression of func-
tionally active L/F-transferase from these truncated aat
fragments was dependent on plasmid-encoded transcription
and translation signals and that a cryptic Shine-Dalgarno
sequence and start codon existed only in the 0 and -1
reading frames.
The results of other aat expression tests were consistent
with this explanation. Specifically, the PvuII (pGEM2 poly-
linker)-SspI (2791) fragments from clones W1 and W3 were
isolated and cloned into the EcoRV site of plasmid pBR322.
This approach has the potential to position the aat ORF in
either orientation inside the tet gene of pBR322. However,
no clones in which the aat gene was positioned in the sense
orientation with respect to the tet gene were recovered for
either fragment. Isolation and retransformation of the result-
ing plasmids into TS351 cells that carried pUBP-R-Pgal
resulted in white colonies for the Wi-derived pAS31 vector
(complementation of the Arg-Pgal degradation defect) and
blue colonies for the W3-derived pAS32 vector (lack of
complementation; see Materials and Methods). We conclude
that the entire aat ORF and more than 30 bp of upstream
DNA are required for L/F-transferase expression in this
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MdrH:2 RALLPYLALYKRHKWMLSL .....GIVLAIVTL.......... LASIGLL 36
11 11 :11 :. :::: 1::. 1.::
CyaB:72 RAPLPAIALDRQGGYFVLVPRFEPGADQAVLIQRPGQAPARLGQAEFEAL 121
MdrH:37 TLSGWFLSASAVAGVAGL ..YSFNYMLPA.............. 63
CyaB:122 WAGELLLCACAASPTQALARFDFSWFIPALVKHRHLIGEVLLISLVLQFI 171
MdrH:64 ..........AGVRGAAITRTAGRYFERLVSHDATF... 89
..:.. .:. 1: .11 1:. 1:
CyaB:172 SLLTPLFFQVVMDKVLVNNAMETLNVITVGFLAAILFEALLTGIRTYLFA 221
MdrH:90 .... RVLQHLRIYTFSKLLPLSPAGLARYRQGELLNRVVADVDTLDHLYL 135
CyaB:222 HTSSKLDVELGARLYAHLLRLPLA.... YFQARRVGDSVARVRELEHIRA 267
MdrH:136 RVISPLVGAF.. VVIMVVTIGLSFLDFTLAFTLGGIMLLTLFLMPPLFYR 183
:.: 1..: 11: 11 I:: 1: :.: :11..: 1. 31.
CyaB :268 FLTGNAVTVLLDVVFSVVFIAVMFF.YSVKLTLVVLAALPCYFLLSLVLT 316
MdrH: 184
CyaB: 317
MdrH:233
CyaB:367
AGKSTGQNLTHLRGQYRQQ.LTAWLQGQAELTIFGASDRYRTQLENTEIQ 232
::. II .1. I.. : ..:. ::....:..::.
PVLRRRLHVKFNRGAENQAFLVETVSGIDTVKSLAVEPQWQRNWDRQLAG 366
WLEAQRRQSELTALSQAIMLLIGALAVILMLWMASGGVGGNAQPGA.... 278
::.I :11 I1: :::. :1.1: :: . G:.1 1:.1:
YVAA..... GLSVANVAMLANTGVTLISRLLRWESCGWAHRGGRARM 408
MdrH:279 .... LIALFVFCALAAFEALAPVTGAFQHLGQVIASAVRISDLTDQKPEV 324
1:1: :::: .. ::: .:..1 1:: : : :.II
CyaB:409 TVGELVAFNMLSGHVT.QPVIRLAQLWNDFQQTGVSMQRLGDILNCRTEV 457
MdrH:325
CyaB:458
TFPDTQTRVADRVSLTLRDVQFTYPEQSQQALKGISLQVNAGEHIAILGR 374
. ...I . 11:.1 I ::::II
AGDKAQLP.ALRGSIELDRVSFRYRPDAADALRNVSLRIAPGEVVGVVGR 506
MdrH:375 TGCGKSTLLQQLTRAWDPQQGEILLNDSPIASLNEAALRQTISVVPQRVH 424
a 1:11111 .T:IL:::. I:1::: I: ::.1. QGE::I T 5
CyaB:507 SGSGKSTLTRLIQRMFVADRGRVLIDGHDIGIVDSASLRRQLGVVLQEST 556
MdrH:425
CyaB:557
LFSATLRDNLLLASPGSSDEALSEILRRVGLEKLLED..AGLNSWLGEGG 472
11. .:I I: 1.11.1 ..: . .1 ..:::
LFNRSVRDNIALTRPGASMHEVVAAARLAGAHEFICQLPEGYDTMLGENG 606
MdrH:473 RQLSGGELRRLAIARALLHDAPLVLLDEPTEGLDATTESQILELLAEMMR 522
.1111: .1::11111:1. 67V I 6
CyaB:607 VGLSGGQRQRIGIARALIHRPRVLILDEATSALDYESEHIIQRNMRDICD 656
MdrH:523
CyaB:657
EKTVLMVTHRLRGLSRFQQIIVMDNGQIIEQGTHAELLARQGRYYQFKQ 571
GRTVI::.111.::. :.1:1:.1: 1.1..111 .1 .:..
GR'IVIIIAHRLSAVRCADRIVVMEGGEVAECGSHETLLAAGGLYARLQA 705
FIG. 3. Comparison of the deduced amino acid sequence of the MdrH protein (this work) with the deduced sequence of the CyaB protein
from B. pertussis (17). The sequence of the MdrH protein contains several highly hydrophobic stretches (residues 16 to 57, 96 to 112, 137 to
158, 160 to 182, and 249 to 272) characteristic of membrane-spanning regions. The ATP-binding motif (LSGGXXXRLXIA) (23) is present in
the C-terminal portion of MdrH (residues 475 to 486).
environment. Furthermore, the complete absence of clones
in which the aat gene was positioned in the same orientation
as the disrupted tet gene (data not shown) suggested that
overexpression of L/F-transferase from multiple copies of
the pBR322 Pte, promoter is deleterious to the cell. Interest-
ingly, the ability of plasmids expressing the M7 or M11
fragment of aat to complement partially the Arg-,Bgal degra-
dation defect in TS351 cells (Fig. 4A) indicated that a
deletion of the N-terminal -15% of L/F-transferase does not
completely abolish its enzymatic activity.
A second deletion series was created to define more
precisely the sequences required for L/F-transferase expres-
sion. In this series, four copies of the transcriptional termi-
nator from the E. coli rRNA operon (9) were positioned
immediately upstream of the deletion clones to reduce the
influence of the plasmid-based expression signals that com-
plicated interpretation of the data obtained with the first
deletion series. As shown in Fig. 4B, clones as long as T14-2
and T14-6 did not complement the TS351 mutant, while clone
T14-18 (which contained the complete aat ORF and 83 bp of
the upstream sequence) resulted in full complementation, asjudged by colony color on X-Gal plates. The constraints
provided by these deletion data, as well as similarities
between the known cr70-dependent E. coli promoters and the
-50-bp region immediately upstream of the aat ORF, indi-
cated that this region functioned as a promoter in plasmid-
based constructs. The relative contribution of this intraop-
eron promoter to the in vitro expression of L/F-transferase
remains to be determined.
The 3' end ofaat and the infA gene. Transformants carrying
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J: A(1398) ATG(1787)
Pl ~ ~ II
aat
-a
Clone First nucleotide
W1 1715-8
W2
W3
W4
M7&M11
M8
M9
M10 & M12
B13
B17 & B18
B
S A=(1398)
Clone
T14-2
T14-6
1808
1819
1721
1880
1814
1847
1846
1845
1910
M/C
Arg-pgal degradation
+
+/
+/-
+/-
+/-
IATG(1787)
Haat _-- I 0S/
Ss/Pv
First nucleotide
1758
1763
Arg-,Bgal degradation
T14-18 1705 +
FIG. 4. Deletion constructs used to determine the sequences required for the expression of L/F-transferase. The initial plasmids were
pAS17 (A) and pAS45 (B). For each deletion product, the first nucleotide of the E. coli DNA insert not deleted by exonuclease III (Exo III)
and the ability of the recircularized plasmid to complement the Arg-Pgal degradation defect in TS351 cells are indicated. In each case,
treatments with exonuclease III deleted sequences upstream of the aat gene, while the opposite end of the fragment was protected by its 3'
extension. Abbreviations: P, PstI; A, AvaI; ATG, start codon of the aat gene; M, SmaI; C, ScaI; Ss, SspI; Pv, PvuII.
the plasmids generated in the first deletion series (see above
and Fig. 4A) formed smaller colonies than transformants
carrying either the plasmids generated in the second deletion
series or plasmid pAS31 (or pAS32), which had aat inserted
within the tet gene. The growth deficiency caused by the first
series of plasmids stemmed from the presence of the infA
gene in the BglII (1366)-ScaI (3077) fragment (Fig. 1) used to
isolate the deletion fragments shown in Fig. 4A. Indeed,
plasmids such as pAS45, derived from the BglII (1366)-SspI
(2791) fragment, which encoded only an N-terminal region of
the Infl protein, did not confer a slow-growth phenotype
(data not shown). Furthermore, transformation of TS351
(aat-2::minitet) with pAS25, which was produced from
pAS17 (see Materials and Methods) by deletion of its 346-bp
KpnI (2458 to 2806) fragment (Fig. 1), yielded large blue
colonies on X-Gal plates. The latter deletion removed the
sequences encoding the last 8 residues of L/F-transferase
through those encoding the first 11 residues of Infl (Fig. 1
and data not shown). Thus, multiple copies of the infA gene
appear to be deleterious, at least in the backgrounds of the
tested E. coli strains. In addition, the lack of complementa-
tion by plasmid pAS25 showed that even small deletions at
the C terminus of L/F-transferase abolish its activity.
In vivo modification of Arg-j3gal. Previous evidence that
the degradation of the engineered N-end rule substrate
Arg-fgal proceeds through a (Phe or Leu)-Arg-,Bgal interme-
diate was largely indirect. A functional aat gene is required
for the degradation of Arg-Ogal and Lys-,gal in E. coli,
whereas the degradation of Phe-3gal and Leu-Pgal is inde-
pendent of aat (42). To test directly for the N-terminal
modification of an N-end rule substrate, Arg-Pgal was over-
expressed in and purified from E. coli JT111 cells (see
Materials and Methods). This strain is aat+ but contains a
clpA14::minitet mutation that blocks the degradation of all
N-end rule substrates (42) and thus allows their overexpres-
sion. The results of N-terminal sequencing of the isolated
Arg-Pgal confirmed the role of L/F-transferase in the in vivo
degradation of Arg-jgal but were also unexpected in several
respects. In the presence of isopropyl-p-D-thiogalactopyra-
noside (IPTG), the initial fusion, Ub-Arg-pgal, was ex-
pressed to near toxic levels from the Ptrc promoter. None-
theless, the bulk of Ub-Arg-,3gal was deubiquitinated by the
Ubpl protease (expressed from plasmid pJT184; 43). More-
over, -70% of the resulting Arg-,gal was modified by
L/F-transferase, a nonabundant enzyme (14) produced from
a scarce mRNA (12). In contrast to the results of in vitro
studies with partially purified L/F-transferase, which cata-
lyzed the efficient conjugation of either Phe or Leu (and the
less efficient conjugation of Met) to the N termini of test
substrates (14), the N-terminal modification of Arg-3gal in
vivo was found to involve exclusively the conjugation of Leu
(Materials and Methods and data not shown). Thus, the in
A
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vivo selectivity of L/F-transferase is greater than that ob-
served with the isolated enzyme.
DISCUSSION
We have extended our previous observation that L/F-
transferase is a component of the N-end rule pathway in E.
coli (42). The involvement of L/F-transferase in proteolysis
mirrors a similar involvement of R-transferase in the N-end
rule pathway of eukaryotic cells. In either pathway, the
N-terminal conjugation of a primary destabilizing amino acid
serves as a signal for the degradation of the modified protein.
Although each of these aminoacyl-tRNA-protein trans-
ferases catalyzes the posttranslational N-terminal aminoacy-
lation of acceptor proteins, their amino acid sequences are
dissimilar from one another and from other sequences in
current data bases. Furthermore, bacterial L/F-transferase is
about half the size of yeast R-transferase (234 versus 503
residues) (4); it is also considerably smaller than the smallest
aminoacyl-tRNA synthetase (10). The small size of E. coli
LIF-transferase is particularly noteworthy in light of the
demonstrated ability of the enzyme to bind specific ami-
noacyl-tRNAs, to discriminate between cognate and non-
cognate aminoacyl residues in a mischarged aminoacyl-
tRNA, to recognize specific N-terminal residues in
substrates of L/F-transferase, and to catalyze peptide bond
formation (40). On the basis of our deletion analysis, the
enzymatic activity of L/F-transferase depends only weakly
on the presence of the N-terminal -15% of its sequence,
whereas even small C-terminal deletions abolish the activity.
The in vivo specificity of L/F-transferase differs from that
determined previously with a partially purified enzyme or
whole-cell extracts. In vitro, L/F-transferase catalyzes the
conjugation of Phe, Leu, or (at lower levels) Met residues to
the N termini of proteins bearing N-terminal Lys or Arg (40).
In contrast, when Arg-IBgal was expressed from the Ptrc
promoter in the presence of the wild-type chromosomal copy
of the aat gene, the resulting Arg-ogal was found either to be
completely unmodified or to contain an N-terminal Leu
residue; no conjugation of Phe or Met could be detected in
vivo (see Results). This greater specificity in vivo presum-
ably reflects a higher stringency for the recognition of
aminoacyl-tRNAs and suggests that another protein, missing
in an active form from cell extracts, may act to increase the
specificity of LIF-transferase. Earlier biochemical evidence
that the isolated L/F-transferase catalyzes the complete
conjugation reaction (40) suggests that additional subunits
would be limited to a regulatory role. Consistent with the
existence of additional subunits are biochemical data indi-
cating that LIF-transferase activity fractionates as a high-
molecular-mass complex (>25 kDa) during gel chromatogra-
phy of crude E. coli extracts (14).
The greater specificity of L/F-transferase in vivo (com-
pared with the findings obtained with cell-free enzymatic
assays) was also suggested by our previous in vivo findings
(42). In in vitro studies, the dipeptides Arg-Ala, Lys-Ala,
and (at higher concentrations) His-Ala were found to inhibit
the aminoacylation of ac-casein catalyzed by L/F-transferase
(a-casein contains an N-terminal Arg residue) (40). No other
dipeptide of the form X-Ala could inhibit this reaction. These
results were interpreted to mean that N-terminal His could
act as a substrate for N-terminal aminoacylation by LIF-
transferase. However, the in vivo half-life of His-,gal in E.
coli was found to be indistinguishable from those of the other
long-lived X-,gal proteins (42), indicating that L/F-trans-
ferase-mediated aminoacylation of His-,gal (and its subse-
quent degradation by the Clp protease) was negligible in
vivo.
The possibility that the presently known set of compo-
nents of the N-end rule pathway in E. coli is incomplete is
consistent with our inability to reconstruct the N-end rule
pathway in vitro. Assays with purified Clp protease (a gift
from M. Maurizi, National Institutes of Health) and purified
X-fBgal proteins yielded little degradation of X-Pgal proteins
and no differential degradation that depended on the identity
of an N-terminal residue (data not shown). This result may
have been due to the absence of a putative N-recognin-like
component in these assays. In the eukaryotic N-end rule
pathway, an N-recognin (also called E3) binds to a primary
destabilizing N-terminal residue of an N-end rule substrate
and initiates a cascade of reactions that result in substrate
degradation (5).
We have screened for mutations that stabilize Arg-Pgal in
E. coli by using both transposon mutagenesis and the chem-
ical mutagen ethyl methanesulfonate. To date, these screens
have identified only the clpA and aat genes as components of
the N-end rule pathway. Although this result would normally
suggest that a screen is saturated, these screens have failed
to yield mutations in clpP, which encodes the second subunit
of the Clp protease (33). A constructed E. coli strain in which
the central 55% of the clpP gene was replaced with a
kanamycin resistance marker yielded blue colonies when
transformed with either pUBP-R-Pgal or pUBP-L-IPgal,
demonstrating that clpP is also essential for the degradation
of N-end rule substrates in E. coli. The failure of our screens
to identify an E. coli N-recognin might have resulted from
this protein having an additional function that is essential for
cell viability (inactivation of the N-end rule pathway is not
lethal; 42) or from the existence of multiple, functionally
overlapping N-recognins in E. coli. Recently, a selection-
based screen in which the modified TnS Kan protein, which
specifies kanamycin resistance, was used as an N-end rule
reporter substrate was developed. This screen, which did
reveal an N-end rule-inactivating mutation in the clpP gene,
is being used to search for other components of the N-end
rule pathway (31a).
The aat gene maps to 19 min of the E. coli chromosome.
This definitive position differs from a previous tentative
mapping of aat to -55 min (41). We have shown that aat is
the last gene of a new operon that contains at least one
additional ORF, termed mdrH. The deduced amino acid
sequence encoded by the mdrH ORF is highly similar to the
sequences of mammalian Mdr P glycoproteins. Other exam-
ples ofmdrH homologs from bacteria include the hylB gene,
required for hemolysin transport in uropathogenic E. coli
strains (7), and the cyaB gene, implicated in the export of the
calmodulin-sensitive adenylate cyclase-hemolysin bifunc-
tional protein of B. pertussis (17). E. coli MdrH is also
homologous to a family of bacterial membrane importers.
These proteins, which include OppF and HisP, share a
putative ATP-binding motif (23) with genes from the Mdr
family (23). The sequence of MdrH is more similar to that of
CyaB than it is to the sequences of bacterial importers
involved in the membrane transport of small metabolites,
suggesting that MdrH mediates the translocation of (un-
known) peptides or proteins across an E. coli membrane
(23).
The transcriptional coupling of mdrH and aat suggests a
functional connection between the enzymes encoded by
these genes. This possibility is particularly interesting in
light of recently published mapping data (13). The genes
cydC and cydD have been localized on the E. coli chromo-
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some to the region immediately adjacent to the infA gene,
which encodes translational initiation factor Infl. In the
published map (13), the positions of cydC and cydD (13)
appear to be identical to the positions demonstrated here to
contain, respectively, aat and mdrH (Fig. 2). The cydC and
cydD genes do not encode known components of the cyto-
chrome d enzyme but are nonetheless essential for the
expression of a functional cytochrome d (16, 35). Cyto-
chrome d is a terminal oxidase that mediates E. coli respi-
ration under conditions of low oxygen tension. Interestingly,
at high oxygen tensions, this enzyme is replaced by the
cytochrome o terminal oxidase. Thus, the replacements of
specific terminal oxidases in response to changing oxygen
tensions might involve L/F-transferase-dependent degrada-
tion of an old cytochrome or L/F-transferase-dependent
transport of a new cytochrome to its position in the inner
membrane. However, recent tests of these possibilities
indicated that aat is distinct from cydD, because a mutant
bearing a precise deletion of the aat gene did not have the
phenotypes characteristic of mutations in cydD or function-
ally related genes (31a).
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